Along with the ageing of the population in Czech Republic, the age-related macular degeneration becomes a serious problem. Terminal stages of this disease lead to very low visual acuity close to the practical blindness which becomes an important socioeconomic problem. Age-related macular degeneration affects 30% patients older than 75 years. The effort of all therapeutic procedures developed in the last 25 years is to guarantee to patients with age-related macular degeneration prolongation of the effective visual acuity.